Lexicon Pharmaceuticals shares owned by Group One Trading
Quarter-by-quarter ownership of Lexicon Pharmaceuticals shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Lexicon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Lexicon Pharmaceuticals held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Lexicon Pharmaceuticals by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $34k | 25k | 1.35 |
| 2025-06-30 | $15k | 16k | 0.95 |
| 2025-03-31 | $14k | 31k | 0.46 |
| 2024-12-31 | $29k | 40k | 0.74 |
| 2024-09-30 | $68k | 43k | 1.57 |
| 2024-06-30 | $54k | 32k | 1.68 |
| 2024-03-31 | $106k | 44k | 2.40 |
| 2023-09-30 | $55k | 50k | 1.09 |
| 2023-06-30 | $406k | 177k | 2.29 |
| 2023-03-31 | $15k | 6.2k | 2.43 |
| 2022-12-31 | $1.1k | 600 | 1.91 |
| 2022-09-30 | $3.0k | 1.4k | 2.14 |
| 2022-06-30 | $47k | 25k | 1.87 |
| 2022-03-31 | $999 | 300 | 3.33 |
| 2021-12-31 | $72k | 18k | 3.96 |
| 2021-09-30 | $167k | 35k | 4.81 |
| 2021-06-30 | $56k | 12k | 4.55 |
| 2021-03-31 | $240k | 41k | 5.87 |
| 2020-12-31 | $129k | 38k | 3.42 |
| 2020-09-30 | $6.0k | 4.0k | 1.50 |
| 2020-06-30 | $25k | 12k | 2.03 |
| 2020-03-31 | $53k | 27k | 1.96 |
| 2019-12-31 | $111k | 27k | 4.16 |
| 2019-09-30 | $241k | 80k | 3.01 |
| 2019-06-30 | $57k | 9.0k | 6.33 |
| 2019-03-31 | $92k | 17k | 5.58 |
| 2018-12-31 | $179k | 27k | 6.63 |
| 2018-09-30 | $288k | 27k | 10.67 |
| 2018-06-30 | $24k | 2.0k | 12.00 |
| 2017-09-30 | $1.2M | 98k | 12.30 |
| 2017-06-30 | $122k | 7.4k | 16.49 |
| 2017-03-31 | $171k | 12k | 14.37 |
| 2016-12-31 | $631k | 46k | 13.84 |
| 2016-09-30 | $108k | 6.0k | 18.00 |
| 2016-06-30 | $342k | 24k | 14.37 |
| 2016-03-31 | $74k | 6.2k | 11.94 |
| 2015-12-31 | $186k | 14k | 13.29 |
| 2015-09-30 | $308k | 29k | 10.73 |
| 2015-06-30 | $16k | 2.0k | 8.00 |
Top funds holding Lexicon Pharmaceuticals
View all funds holding Lexicon Pharmaceuticals